• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Kodiak Sciences Inc (NQ: KOD )

    4.380 +0.480 (+12.31%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 5, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Kodiak Sciences Inc

    < Previous 1 2 3 4 Next >
    38 Stocks Moving In Tuesday's Mid-Day Session
    Gainers Kiromic BioPharma, Inc. (NASDAQ: KRBP) gained 70% to $0.4900 after the company entered a sponsored research agreement under which in vivo preclinical data will be generated from Kiromic's Gamma... 
    Via Benzinga
    United Airlines And 3 Other Stocks Insiders Are Buying
    Although US stocks closed slightly higher on Monday, there were a few notable insider trades. 
    Via Benzinga
    Carnival And 3 Other Stocks Insiders Are Buying
    Although the Dow Jones jumped around 575 points on Friday, there were a few notable insider trades. 
    Via Benzinga
    38 Stocks Moving In Thursday's Mid-Day Session
    Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares climbed 34.6% to $4.1993 after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid for... 
    Via Benzinga
    71 Biggest Movers From Yesterday
    Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares jumped 76.3% to close at $5.50 on Thursday after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation... 
    Via Benzinga
    The Daily Biotech Pulse: Valneva's COVID-19 Vaccine Filing Accepted By EMA, Enanta's RSV Candidate Fails, Orphan Drug Tag For Mersana's Gastric Cancer Candidate
    Here's a roundup of top developments in the biotech space over the last 24 hours: 
    Via Benzinga
    What 5 Analyst Ratings Have To Say About Kodiak Sciences
    Within the last quarter, Kodiak Sciences (NASDAQ:KOD) has observed the following analyst ratings: 
    Via Benzinga
    Analyst Ratings for Kodiak Sciences
    Within the last quarter, Kodiak Sciences (NASDAQ:KOD) has observed the following analyst ratings: 
    Via Benzinga
    24 Stocks Moving in Thursday's Pre-Market Session
    Gainers Acorda Therapeutics, Inc. (NASDAQ: ACOR) shares rose 20.9% to $0.70 in pre-market trading after dropping 12% on Wednesday. Acorda Therapeutics recently posted a Q1 loss of $1.66 per share. 
    Via Benzinga
    The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs
    Here's a roundup of top developments in the biotech space over the last 24 hours. 
    Via Benzinga
    The Week Ahead In Biotech (May 1-7): Phathom FDA Decision, Pfizer, Vertex Pharma Lead Earnings News, Ophthalmology Conference Presentations, And More
    Biotech stocks posted weekly declines yet again in the week ending April 29, taking cues from the weak broader market sentiment. Big pharma earnings, clinical readouts and pipeline updates moved stocks... 
    Via Benzinga
    Bonds Are Screaming “Recession.” That’s Great News For One Top Sector.
    The 10-2 year treasury yield spread is close to zero. Here's what you should do about this warning sign of a coming recession. 
    Via InvestorPlace
    Stocks That Hit 52-Week Lows On Wednesday
    Wednesday's session saw 107 companies set new 52-week lows. Points of Interest From Today's 52-Week Lows: Citigroup (NYSE:C) was the largest company by... 
    Via Benzinga
    Recap: Kodiak Sciences Q4 Earnings
    Kodiak Sciences (NASDAQ:KOD) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:10 PM. Here's what investors need to know about the announcement. Earnings Kodiak... 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Gainers IsoPlexis (NASDAQ:ISO) shares moved upwards by 22.8% to $5.5 during Wednesday's pre-market session. The company's market cap stands at $214.2 million. The... 
    Via Benzinga
    The Daily Biotech Pulse: Karyopharm Flags Delay In Selinexor Label Expansion, Finch, Celyad Hit With Clinical Holds, Adagene Strikes R&D Collaboration With Sanofi
    Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Karyopharm Says FDA Mandates Additional Study For Expanding Selinexor Label... 
    Via Benzinga
    28 Stocks Moving in Wednesday's Pre-Market Session
    Gainers Guardion Health Sciences, Inc. (NASDAQ: GHSI) rose 46.4% to $0.4098 in pre-market trading after jumping around 48% on Tuesday. Guardion Health Sciences recently reported... 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Wednesday
    On Wednesday, 348 companies hit new 52-week lows. Significant Points From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was... 
    Via Benzinga
    The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight
    Biopharma stocks lock-stepped with the broader market in the week ending Feb. 25 before finishing higher. The trajectory was the same, with the sector declining in the first two sessions of the... 
    Via Talk Markets
    The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight
    Biopharma stocks lock-stepped with the broader market in the week ending Feb. 25 before finishing higher. The trajectory was the same, with the sector declining in the first... 
    Via Benzinga
    3 Moonshot Stocks Insiders Are Buying. What Do They Know?
    Biotech stocks aren't a sure thing, but one good sign is insiders buying up shares. These three all offer that enticing feature. 
    Via InvestorPlace
    Expert Ratings For Kodiak Sciences
    Analysts have provided the following ratings for Kodiak Sciences (NASDAQ:KOD) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total... 
    Via Benzinga
    10 Biggest Price Target Changes For Thursday
    SVB Leerink lowered Guardant Health, Inc. (NASDAQ: GH) price target from $170 to $140. Guardant Health shares dropped 5.7% to $56.22 in pre-market trading. 
    Via Benzinga
    63 Biggest Movers From Yesterday
    Gainers Tenneco Inc. (NYSE: TEN) shares surged 93.9% to close at $19.35 on Wednesday after the company announced it will be acquired by Apollo Funds. Tenneco also reported a... 
    Via Benzinga
    KOD Stock Alert: Why Is Kodiak Sciences Plunging 80% Today?
    Disappointing drug trial results have sent Kodiak Sciences and shares of KOD stock plunging more than 80% in today's trading session. 
    Via InvestorPlace
    Mid-Afternoon Market Update: U.S. Stocks Extend Losses; Dow Dips 300 Points
    U.S. stocks extended losses toward the end of trading, with the Dow Jones falling 300 points on Wednesday. US President Biden late Tuesday announced sanctions on some Russian... 
    Via Benzinga
    Mid-Day Market Update: U.S. Stocks Turn Negative; Nasdaq Drops 50 Points
    U.S. stocks turned lower midway through trading after recording sharp losses on Tuesday. US President Biden late Tuesday announced sanctions on some Russian banks and individuals... 
    Via Benzinga
    S&P 500 Slips Further into Correction Territory as Stocks Give Up Gains
    Stocks have pulled back from this morning's gains, amid the ongoing Russia-Ukraine border crisis, with all three benchmarks looking to extend their losing streaks. 
    Via Talk Markets
    40 Stocks Moving In Wednesday's Mid-Day Session
    Gainers Tenneco Inc. (NYSE: TEN) shares jumped 94.1% to $19.38 after the company announced it will be acquired by Apollo Funds. Tenneco also reported a Q4 loss of $0.11 per share... 
    Via Benzinga
    Kodiak Stock Pummeled After Attempt To Improve On Regeneron's Blockbuster Backfired
    Kodiak hoped a less frequent dosing plan would benefit patients with an eye disease. 
    Via Investor's Business Daily
    < Previous 1 2 3 4 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.